This undated image provided by Merck & Co. shows their new antiviral medication. Pharmaceutical company Merck & Co. announced Friday, Oct. 1, 2021, that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use. (AP)
Prepare Now Before its too Late
Discover where products are available & compare prices
